Proteomic phenotyping of metastatic melanoma reveals putative signatures of MEK inhibitor response and prognosis

Christoph Krisp, Robert Parker, Dana Pascovici, Nicholas K. Hayward, James S. Wilmott, John F. Thompson, Graham J. Mann, Georgina V. Long, Richard A. Scolyer, Mark P. Molloy^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review